Abstract Aims SPARCL1 was recently identified as a biomarker of right ventricular (RV) maladaptation in patients with pulmonary hypertension (PH), and N‐terminal pro‐brain natriuretic protein (NT‐proBNP) is an established biomarker of RV failure in PH. The present study investigated whether NT‐proBNP and SPARCL1 concentrations are associated with load ...
Oliver Dörr +15 more
wiley +1 more source
Coronary calcium score in patients with post-surgical hypoparathyroidism. [PDF]
de Souza Sartori JF +5 more
europepmc +1 more source
Relation of <i>JAK2</i> V617F allele burden and coronary calcium score in patients with essential thrombocythemia. [PDF]
Drofenik A +5 more
europepmc +1 more source
Coronary calcium score and emphysema extent on different CT radiation dose protocols in lung cancer screening. [PDF]
Ledda RE +10 more
europepmc +1 more source
Correction to "Nomenclature revision may mitigate potential overtreatment of incidental finding of coronary calcium on chest computed tomography". [PDF]
europepmc +1 more source
Coronary Calcium Scoring Using True and Virtual Non-Contrast Reconstructions on Photon-Counting CT with Differing Slice Increment: Impact on Calcium Severity Classifications. [PDF]
Kaldas M +8 more
europepmc +1 more source
Comparative Prognostic Value of Coronary Calcium Score and Perivascular Fat Attenuation Index in Coronary Artery Disease. [PDF]
Savo MT +15 more
europepmc +1 more source
Related searches:
In the search of coronary calcium
International Journal of Cardiology, 2013The recognition of coronary artery calcium (CAC) as an indicator of coronary artery disease for more than 30 years has created a great interest in methods for its accurate assessment. In this review we present the imaging techniques capable of detecting CAC and discuss their current status in clinical practice. The first non-invasive CAC imaging method
Dimitrios, Alexopoulos +1 more
openaire +2 more sources
While there is no doubt that high-risk patients (those with more than a 20% 10-year risk of a future cardiovascular event) need more aggressive preventive therapy, a majority of cardiovascular events occur in individuals at intermediate risk (10%-20% 10-year risk).
Ambarish, Gopal, Matthew J, Budoff
openaire +2 more sources

